Neuland Laboratories Vállalati érték
Mi az Neuland Laboratories Vállalati érték?
A Vállalati érték az Neuland Laboratories Limited - $318.08M
Mi a Vállalati érték meghatározása?
A vállalati érték a vállalat teljes piaci értékének mértéke. A piaci kapitalizáció az adósság, a kisebbségi részesedés és a preferált részvények összege, a pénzeszközök és pénzeszköz-egyenértékek összege mínusz.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Vállalati érték a Health Care szektor a BSE-on cégekben a Neuland Laboratories -hoz képest
Mit csinál Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
vállalati érték -hoz hasonló cégek Neuland Laboratories
- Madras Fertilizers nak Vállalati érték $317.43M van
- Voltamp Transformers nak Vállalati érték $317.51M van
- Zuari Agro Chemicals nak Vállalati érték $317.66M van
- Budding Times nak Vállalati érték $317.73M van
- Schroder UK Mid Cap Fund Plc nak Vállalati érték $317.77M van
- Chiho Environmental nak Vállalati érték $317.93M van
- Neuland Laboratories nak Vállalati érték $318.08M van
- Newton Resources Ltd nak Vállalati érték $318.13M van
- Akebia Therapeutics nak Vállalati érték $318.16M van
- TMAC Resources nak Vállalati érték $318.89M van
- accesso Technology Plc nak Vállalati érték $319.15M van
- Noranda Income Fund nak Vállalati érték $319.19M van
- Discovery Metals nak Vállalati érték $319.21M van